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See related viewpoint by Marik and Bellomo, http://ccforum.com/content/17/2/305Marik and Bellomo reason that stress hyperglycemia
might be an essential survival response [1]. We reviewed
the same question in this journal, before multi-center
studies on glycemic control were published [2]. It strikes
us that of almost all novel therapies in septic patients,
few appear to withstand time. If everything has been fu-
tile, did we cause iatrogenic damage, as suggested [1],
and is there reason to become cynical? We think the ori-
ginal studies gave rise to good developments. First, the
Rivers protocol led to the implementation of limited sep-
sis treatment bundles resulting in a mortality decrease.
Second, the results and the glycemic control of studies
by Greet van den Berghe appeared to be not that simple
to achieve in real life. Third, lactate-guided therapy im-
proved outcomes, although without an exactly known* Correspondence: j.j.m.ligtenberg@umcg.nl
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Full list of author information is available at the end of the article
Authors' response
Paul E Marik and Rinaldo Bellomo
© BioMed Central Ltd.2014mechanism [3]. Fourth, a subset analysis of the Surviving
Sepsis Campaign database including nearly 9,000 pa-
tients revealed that low-dose steroid treatment is associ-
ated with an increase in hospital mortality [4]. Fifth,
look at all the hemodynamic optimization trials… Not-
withstanding the disappointing results of follow-up stud-
ies, the original studies were important because they
increased recognition of septic patients, led to more ori-
ginal ideas [5], and to effective treatment bundles not
funded by third parties [6]. An important common de-
nominator is the intensive attention that all these studies
required for their execution, increasing the recognition
of septic patients and re-evaluating treatment in a timely
manner. These initial studies should make us humble
and proud at the same time.We thank Dr Ligtenberg and colleagues for their com-
ments regarding our paper on stress hyperglycemia [1].
We would argue that tight glycemic control may have
led to patients receiving therapy that was harmful (too
much insulin) [7], that the Rivers protocol has not been
validated and may have led to harm (too much fluid, too
much blood) [8,9] and that lactate-guided therapy is a
misnomer as an oxygen debt is unlikely in sepsis and
this approach will lead to excessive interventions (too
much fluid, inotropic agents and blood) [10,11]. The
steroid effect reported from the Surviving Sepsis
Campaign database may just represent selection bias [4].
We advocate a healthy dose of skepticism rather than
cynicism. Furthermore, when it comes to the critically
ill, ‘less may be more’ [12].Competing interests
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